NMRA
NMRA clinical trials: Neumora Therapeutics, Inc.
Every trial on ClinicalTrials.gov where Neumora Therapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 7
- Trials linked
- 7
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
NMRA on the catalyst calendar · NMRA registry changes
- Primary completion Nov 19, 2025ActualPhase 1NCT06546995Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's...Neumora Therapeutics, Inc. · Alzheimer's DiseaseCompletedNMRALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 17, 2026ActualPhase 3NCT06029439Study to Assess the Safety and Effectiveness of NMRA-335140-501Neumora Therapeutics, Inc. · Major Depressive DisorderTerminatedNMRALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 4, 2026ActualPhase 3NCT06058039Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive DisorderNeumora Therapeutics, Inc. · Major Depressive DisorderCompletedNMRALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 6, 2026ActualPhase 3NCT06058013Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive DisorderNeumora Therapeutics, Inc. · Major Depressive DisorderCompletedNMRALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 9, 2025ActualPhase 2NCT06429722To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder.Neumora Therapeutics, Inc. · Major Depressive Episode Associated With Bipolar II DisorderCompletedNMRALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 3, 2024ActualPhase 3NCT06029426Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive DisorderNeumora Therapeutics, Inc. · Major Depressive DisorderCompletedNMRALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 8, 2022ActualPhase 2NCT04221230Study in Major Depressive Disorder With NMRA-335140 (BTRX-335140) vs PlaceboNeumora Therapeutics, Inc. · Major Depressive DisorderCompletedNMRALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 7 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner